Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
暂无分享,去创建一个
M. Cerqueira | N. Wong | G. Thomas | J. Narula | R. Senior | D. Agostini | A. Jacobson | F. Weiland | H. Chandna | Victor A. Lopez | V. Lopez
[1] Takashi Morita,et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate v , 2009, Journal of the American College of Cardiology.
[2] P. Camici,et al. 123I-mIBG Scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[3] P. Armstrong,et al. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. , 2009, Annals of internal medicine.
[4] L. Brewster,et al. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. , 2008, European heart journal.
[5] T. Nakata,et al. Predicting the Need for an Implantable Cardioverter Defibrillator Using Cardiac Metaiodobenzylguanidine Activity Together with Plasma Natriuretic Peptide Concentration or Left Ventricular Function , 2008, Journal of Nuclear Medicine.
[6] S. Yamashina,et al. Neuronal imaging using SPECT , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[7] L. Køber,et al. Effect of beta‐blocker therapy on functional status in patients with heart failure — A meta‐analysis , 2006, European journal of heart failure.
[8] G. Breithardt,et al. Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[9] G. Schmidt,et al. Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. , 2004, European heart journal.
[10] P. Merlet,et al. Uptake-1 carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] M. Kurabayashi,et al. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[13] T. Nakata,et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] G. Jennings,et al. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. , 2001, European heart journal.
[15] S. Gerber,et al. The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. , 2001, Journal of molecular and cellular cardiology.
[16] M. Hamon,et al. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] P. Merlet,et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] P. Merlet,et al. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. , 1999, Journal of the American College of Cardiology.
[19] T. Nakata,et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[20] M. Schwaiger,et al. Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. , 1998, Circulation.
[21] M. Böhm,et al. Evidence for reduction of norepinephrine uptake sites in the failing human heart. , 1995, Journal of the American College of Cardiology.
[22] P. Merlet,et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] R. Candinas,et al. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. , 1990, Circulation.
[24] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[25] A. Mark,et al. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. , 1986, Circulation.
[26] Sisson Jc,et al. Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. , 1986, American journal of physiologic imaging.
[27] J. Sisson,et al. Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. , 1986, American journal of physiologic imaging.
[28] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[29] D C Harrison,et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.